Latest / Healthy Living by Willow Creek Springs / Less Radiation, Better Outcomes with Dr Robert Hoffman
Transcript
- 0:12SPEAKER_01: Well, hello and welcome to the Healthy Living Podcast.
- 0:15SPEAKER_01: I'm your host, Joe Grumbine, and today I am very happy to present Dr.
- 0:20SPEAKER_01: Robert Hoffman once again.
- 0:22SPEAKER_01: Robert, welcome back.
- 0:24SPEAKER_01: Glad to be here, Joe.
- 0:25SPEAKER_01: Always.
- 0:26SPEAKER_01: It's always a treat to having a conversation with you.
- 0:29SPEAKER_01: We got a lot to talk about today, a lot of you know leading edge science and even just some commentary on our last Sunday's Zoom call.
- 0:42SPEAKER_01: I think there's just a lot, a lot happening, and it's mostly positive.
- 0:48SPEAKER_01: You know, I have gotten a little spoiled because I've got you now as a friend who ravenously searches the internet and PubMed for articles and developments, and has saved me hundreds of hours of searching myself and in all the wonderful things that you shared.
- 1:15SPEAKER_01: And today who was that?
- 1:17SPEAKER_01: You me.
- 1:19SPEAKER_01: Yeah, yeah, you, you.
- 1:21SPEAKER_01: Anyways, you shared with me an article that you found, and and it was an interesting one because we've talked a lot about cancer treatments and about you know the standard of care model is you know, attack it hard and and hit it with everything, including with things that can often have really negative side effects and even devastating side effects.
- 1:48SPEAKER_01: And we we keep having the conversation that says, well, medicine, right?
- 1:54SPEAKER_01: Hippocratic oath, above all, do no harm, and yet we have these invasive procedures that generally do a lot of harm.
- 2:04SPEAKER_01: And absolutely we we you showed me this article where they had actually had a study of over 250 people that had the same, or many of them had the same cancer as I did.
- 2:19SPEAKER_01: And the the study showed that instead of bombarding the area with up to 80 gray of radiation, they cut it in half almost, and they still found some pretty good results.
- 2:34SPEAKER_01: Why don't you tell us a little bit about your interpretation of all this?
- 2:38SPEAKER_00: Well, Joe, I'm you know, I just found it this morning, and you know, I gave a kind of a brief readover, and so I'm not, you know, I I don't have all the details in my brain, even if I had them, they how long they would stay.
- 2:56SPEAKER_00: But okay, so here my feeling was hey, these guys are starting to get it.
- 3:01SPEAKER_00: Yeah, we have now two publications on your case, two case studies, where we use no radiation.
- 3:09SPEAKER_00: Exactly.
- 3:10SPEAKER_00: Not a complete response.
- 3:11SPEAKER_00: Yeah, these guys are going, well, maybe we can do less.
- 3:15SPEAKER_00: Right.
- 3:16SPEAKER_00: My my take on it, superficial though it is, is hey, you're in the right direction.
- 3:22SPEAKER_00: But uh, why don't you read a couple of our papers?
- 3:24SPEAKER_00: And even though they're just case studies, they're not big fancy clinical trials like yours and jam oncology and all that kind of stuff, but the real science, and we got with you, we got a complete response with no radiation.
- 3:41SPEAKER_00: So exactly my feeling about that study is okay, boys, you're in the right direction.
- 3:48SPEAKER_00: You read a couple of our papers, they're all on PubMed, right?
- 3:53SPEAKER_00: But we don't go there.
- 3:54SPEAKER_01: But so give them I give them a B plus.
- 3:58SPEAKER_01: I yeah, and I I did read into it a little bit, and what I saw was that as a cross-section of people, it was more male than female by a lot, and it was more HPV-driven head and neck cancer as mine was associated, associated, right?
- 4:21SPEAKER_01: Right, right, yeah, associated.
- 4:22SPEAKER_01: There you go.
- 4:23SPEAKER_01: Yeah, we can't we can't say what's causing what because we just don't know, but we know that when this is there, that happens and it seems to respond a little differently.
- 4:30SPEAKER_01: So we're we're we're accepting a correlation, not a causal nature in some way, anyways.
- 4:39SPEAKER_01: I'll rule it out, yeah.
- 4:41SPEAKER_01: Anyways, the one big difference that I saw that I would really love to, like you said, get some of these people to see our paper and juxtapose it to theirs, was that the lion's share of their patients that were in the study were only stage one.
- 5:00SPEAKER_01: And that's that's another percentage that was pretty low was stage two, and a very small percentage was stage three.
- 5:07SPEAKER_01: There were no stage four patients in this study.
- 5:10SPEAKER_01: And when I walked into this, my treatment, I was at stage four, stage four A, so it hadn't gotten metastatic yet, but it was right on the edge and it was wanting to.
- 5:20SPEAKER_01: I believe the treatments that we did kept that from happening.
- 5:24SPEAKER_01: Again, we don't know what did what, but I thought it was pretty interesting that if it seems that they're looking at a treatment that will be a safer treatment or a less harmful treatment as the all got the radiation, right?
- 5:43SPEAKER_00: Right, but just a lot less.
- 5:46SPEAKER_00: They got some the extra that they they called it the elective or whatever radiation.
- 5:51SPEAKER_00: Right.
- 5:52SPEAKER_00: The word they used.
- 5:55SPEAKER_00: And it you know, they either did or didn't, and they didn't see a difference, right?
- 6:00SPEAKER_00: So which is great.
- 6:01SPEAKER_00: So this is this is in a very mainstream journal.
- 6:06SPEAKER_00: Right.
- 6:07SPEAKER_00: And a lot of people are gonna see it, and that's good.
- 6:09SPEAKER_00: Yeah, yeah.
- 6:10SPEAKER_00: Um, and so it's starting to say, hey, maybe you know, maybe the mainstream will catch up to the leading edge someday, which we are exactly, and say, hey, may maybe we we with a lot of you we can just try chemo, and it might give us the complete response without radiation.
- 6:32SPEAKER_00: If it doesn't, and we have to use radiation, we'll use radiation.
- 6:36SPEAKER_01: But you can always add to it, you can always give all the time.
- 6:40SPEAKER_01: That's the part, like for me, even I I said, you know, I don't want to do radiation, but if it turned out that that was my last option, I would have to consider it, you know.
- 6:50SPEAKER_01: We would have needed it.
- 6:51SPEAKER_00: We no, exactly.
- 6:54SPEAKER_00: I think we maximized the chemo.
- 6:56SPEAKER_00: Yeah.
- 6:57SPEAKER_00: And and I I and I don't think I don't know if you could have gotten more or not, but I kind of doubt it.
- 7:03SPEAKER_01: I don't know if I would have wanted it.
- 7:04SPEAKER_00: I barely hung on to that one, yeah.
- 7:06SPEAKER_00: So, you know, if we still had some significant tumor left, we might have had to go to radiation or surgery or both, and we were always open to it.
- 7:15SPEAKER_00: Absolutely.
- 7:17SPEAKER_00: We're gonna try the chemo, the neo adjuvant, and see how far we can go.
- 7:22SPEAKER_00: What's wrong with that?
- 7:23SPEAKER_01: Exactly.
- 7:24SPEAKER_01: And it just seems like that creates, in my opinion, like an obvious roadmap that if we could get that information, which now we have it.
- 7:35SPEAKER_01: I just I just have been sharing the the link to my uh second article with a number of people, and you know, they're scratching their head now.
- 7:44SPEAKER_01: There's you know, when we talk about, you know, a year later and and complete response, when you when you look at even this journal where most of the people were stage one, there was still almost a 10% of the people that didn't survive.
- 8:02SPEAKER_01: And if you looked at that, you know, it was a it was a significant number.
- 8:06SPEAKER_01: It wasn't a huge number, but it was significant for people that were largely stage one and got the radiation and the chemo.
- 8:14SPEAKER_01: Remember, they that was in in concert with the a platinum-based chemo treatment.
- 8:19SPEAKER_01: Didn't get methionine restriction, they didn't mention that at all, or a cocktail like like we did.
- 8:26SPEAKER_00: It was it it never entered anybody's mind.
- 8:29SPEAKER_00: Right.
- 8:30SPEAKER_00: Exactly.
- 8:31SPEAKER_00: The fish in the water didn't know that people are doing something on the land.
- 8:35SPEAKER_01: Exactly.
- 8:36SPEAKER_01: Well, you know, I'd have to add to it the oxidative stress that we brought into it, the fasting, and and of course the methionine restriction and the methioninase, all of those components I believe stacked up with three different chemo drugs.
- 8:53SPEAKER_01: And and I have to think that that combination of three different oxidative stressors, along with the oxygen intake, along with the fasting, along with the restrictive diet and the methionase, all of those things together kind of created this environment that was inhospitable to the cancer, and it just couldn't survive it.
- 9:19SPEAKER_00: That's the hypothesis we have to go on.
- 9:22SPEAKER_00: A whole lot of things, and we don't know uh if we didn't do one of them, what would have happened, we don't know.
- 9:29SPEAKER_00: So we got our hype working hypothesis is that it was everything together, and what's wrong with that?
- 9:37SPEAKER_00: And exactly how we really care.
- 9:40SPEAKER_00: Look at you, you're a CR, you have no exactly no side effects.
- 9:44SPEAKER_00: Uh well, and that's the part I wanted to get to.
- 9:47SPEAKER_01: It's like that you you're you're you're you're back to the old Joe.
- 9:53SPEAKER_01: Exactly.
- 9:53SPEAKER_01: That's what I really wanted to get to, is because the the comparison.
- 10:00SPEAKER_01: Yeah, I I wouldn't have been even a fraction of where I started off if I'd have gone down either the surgery or the radiation or both, because of their known and and certain side effects.
- 10:15SPEAKER_00: And yeah, with head and neck cancer, yeah, surgery is most of all the cancers, it's one of the most debilitating.
- 10:26SPEAKER_00: They take out your jaw, your tongue, you they take out half your face, or whatever the heck they do.
- 10:34SPEAKER_00: Uh, get it all out, I get it, but it they never get it all out.
- 11:31SPEAKER_01: Exactly.
- 11:33SPEAKER_00: You get all this disfigurement, and it comes back.
- 11:37SPEAKER_01: Exactly, exactly.
- 11:39SPEAKER_01: Well, that's where we're at, is keeping it from coming back.
- 11:42SPEAKER_01: And we got the lab report back from the circulating tumor cell DNA test, and that came back not detected.
- 11:51SPEAKER_01: Dr.
- 11:51SPEAKER_01: Song was real happy about that.
- 11:54SPEAKER_01: He's having me go see the ENT, which I'm I'm setting my appointment for that.
- 11:59SPEAKER_01: And you know, again, we talk about this over and over.
- 12:02SPEAKER_01: I'm gonna keep talking about it until I run out of words, which will be never.
- 12:07SPEAKER_01: We we gotta be vigilant and diligent.
- 12:10SPEAKER_00: All your life, all your life, we gotta be, and people might object to that, but being villa diligent and vigilant, sure better than getting a recurrence.
- 12:22SPEAKER_01: Exactly.
- 12:23SPEAKER_01: I I think about sometimes the hassle of the things I have to do, you know, like staying alive, it's okay.
- 12:31SPEAKER_01: Exactly.
- 12:32SPEAKER_01: Exactly.
- 12:33SPEAKER_01: The other day, my wife brought home a plate of shrimp, and her and our our house guests are enjoying it, and I looked at that and I go, Wow, that sure would be tasty.
- 12:42SPEAKER_01: I didn't have a single one.
- 12:44SPEAKER_01: I exactly.
- 12:46SPEAKER_01: And then today the we have a mental health group that comes out here, they brought a box of donuts, and they're like, Well, if you feel like getting off your diet for a minute, I'm like, nope, I'm not gonna do that today.
- 12:57SPEAKER_01: And you know, every once in a while on a real special occasion, I'll have a little break, but it's it it's it, I I I double up the the enzyme and and get back to the diet.
- 13:10SPEAKER_01: And it's uh it's a very occasional thing rather than a normal thing, and it's too easy to slide down that hole.
- 13:17SPEAKER_01: You you start having an over today and a hamburger tomorrow, and the next thing you know, you're right back where you were, and it's just too easy to get overconfident after you've treated.
- 13:32SPEAKER_00: Oh, it's not gonna come back, but it can.
- 13:36SPEAKER_00: Yeah, and you know, and and you you see, you know, Dr.
- 13:41SPEAKER_00: Song, you see how careful he is with you every time you go there.
- 13:45SPEAKER_00: He he's palpating, he's he's very concerned about recurrence that that he's talking about that every time, and now he works ENT doctor, and he's right.
- 14:00SPEAKER_00: I mean, you say, Well, so much worry.
- 14:03SPEAKER_00: It's not a worry.
- 14:05SPEAKER_00: You know, you you have an enemy, uh, an intractable enemy.
- 14:10SPEAKER_00: You got to keep the border guards uh there 24 hours a day, right?
- 14:14SPEAKER_01: 100, 100.
- 14:16SPEAKER_01: I want to switch gears and talk a little bit about Shahiro.
- 14:19SPEAKER_01: She's been a guest on the show, and she's um a partner of yours, and she's an instrumental part of our group.
- 14:27SPEAKER_01: She's an amazing woman who took me when I went to Japan and took me around, and just a very beautiful person.
- 14:35SPEAKER_01: And she's been battling cancer for many years now, and she had a complete recovery as well.
- 14:42SPEAKER_01: But she was on a maintenance program along with the diet and along with the enzyme, but they backed off on the maintenance program to where she was just doing an immunotherapy drug.
- 14:54SPEAKER_01: We stayed, she stayed on the maintenance too long.
- 14:58SPEAKER_00: Yeah, we learned a lot from this.
- 15:01SPEAKER_00: So she she was taking one of these syslibs, the bane or whatever, one of the syslibs.
- 15:07SPEAKER_00: And that was her maintenance, and that she was told, and she took it for about three years, and all the little residual cancer cells that were kind of just sitting there, and some of them became learned how to become resistant to it, and then become and and and so doing, they became much more malignant and aggressive, and and she had uh kind of two steps of very bad recurrence.
- 15:35SPEAKER_00: So there's a big lesson in uh uh her her treatment so far is and we're learn and and this is uh we we the doctor the the uh the guy with the the the the uh the prostate cancer, Dr.
- 15:56SPEAKER_00: Gatenby adaptive therapy.
- 16:00SPEAKER_00: He doesn't want his patients on hormone depletion for long periods of time because he doesn't want the to select for cancer cells that are independent of the hormone and hormone depletion doesn't do anything for them and they become more malignant.
- 16:17SPEAKER_00: So that's a I believe that's a general principle.
- 16:20SPEAKER_00: So Chihiro was on this syslib for too long, and the cancer cells that you know, the little residual cancer cells that we all have, they they became highly resistant and highly malignant.
- 16:36SPEAKER_00: So she uh has a lot of cancer now.
- 16:42SPEAKER_00: And she has uh peritoneal metastasis.
- 16:45SPEAKER_00: This is quite advanced, right?
- 16:48SPEAKER_01: But the good news is is uh the the pet CT she did was inconclusive, right?
- 16:56SPEAKER_01: The the pet CT that she did was in inconclusive.
- 17:01SPEAKER_00: That she just got showed the Met Pet showed it.
- 17:05SPEAKER_00: Yeah, the the the regular uh F DG glucose pet showed some.
- 17:11SPEAKER_00: Okay, the the Met Pet much more detail and much more striking resolution.
- 17:19SPEAKER_00: So okay, so now we're back to work again.
- 17:24SPEAKER_01: But you were able to, you know, you looked at that and and and presented it to Dr.
- 17:30SPEAKER_01: Song, and he agreed that you know, I forget the term that you use, but a chemotherapy drug or a cocktail of drugs that you know he recommended uh uh uh a braxane that's uh nab paxataxyl and carboplatin.
- 17:49SPEAKER_00: I think very good.
- 17:51SPEAKER_00: Okay, so the good news with uh Sihiro now she is on extreme methionine restriction.
- 18:00SPEAKER_00: She's taking about eight vials of methioninase a day.
- 18:05SPEAKER_00: She's on immunotherapy with Ketruda, she's taking ivermectin and she started her own uh hyperthermia.
- 18:18SPEAKER_00: Oh good.
- 18:19SPEAKER_00: She has these tumors in her parentum, the belly area, she can feel it, and she puts on this heat blanket or whatever it is, and I told her to measure the temperature, but I think we're really getting close to 42 degrees centigrade.
- 18:38SPEAKER_00: Nice, and that's kind of the magic number.
- 18:43SPEAKER_00: Oh, I can feel my these lumps, the tumors and the peritoneal metastasis, the carcinomatosis, I can feel them shrinking.
- 18:54SPEAKER_00: Uh she had very bad lower body edema.
- 19:01SPEAKER_00: Right, that's what you were saying.
- 19:03SPEAKER_00: Doctors doctor, especially Dr.
- 19:07SPEAKER_00: Sato said this is due to the draining lymph nodes having a lot of metastasis, they can't function.
- 19:16SPEAKER_00: So her edema is getting better by the day.
- 19:19SPEAKER_00: That's great.
- 19:21SPEAKER_00: So I I'm not sure if she should when she should start Dr.
- 19:28SPEAKER_00: Song's regimen.
- 19:32SPEAKER_00: We're very lucky.
- 19:33SPEAKER_00: We just found out yesterday that Dr.
- 19:36SPEAKER_00: Tsunoda that's also one of her doctors, one of the best oncologists in in the world in Sho University.
- 19:45SPEAKER_00: He's coming here on Friday.
- 19:47SPEAKER_00: Oh wow.
- 19:48SPEAKER_00: Yeah, for just for he's at a meeting in in Phoenix, so he's just taking a day trip here.
- 19:54SPEAKER_00: Okay.
- 19:55SPEAKER_00: More about Sihiro's case.
- 19:57SPEAKER_00: Oh, good.
- 19:59SPEAKER_00: The one of the world leaders in immunotherapy, and which she so we'll see.
- 20:05SPEAKER_00: So I wonder if that we're starting to get there.
- 20:10SPEAKER_00: Joe, Dr.
- 20:11SPEAKER_00: Sado wants to do immunoradiation.
- 20:14SPEAKER_00: Okay.
- 20:15SPEAKER_00: We're starting to think maybe we'll wait a little bit on that.
- 20:19SPEAKER_00: Yeah, see if we do with what we're doing.
- 20:22SPEAKER_00: Yeah, yeah, I I would agree with that.
- 20:24SPEAKER_00: But on Dr.
- 20:25SPEAKER_00: Song's chemo, it won't be easy.
- 20:28SPEAKER_00: That chemo.
- 20:30SPEAKER_00: So maybe we need another MetPet scan in a month or two, and then we can have a uh a scientific basis to kind of what do we need to tell us what we need to do.
- 20:46SPEAKER_01: Uh I wonder if remember Dr.
- 20:49SPEAKER_01: Song had given me that formula for really hot foot bath.
- 20:54SPEAKER_01: Yeah.
- 20:55SPEAKER_01: And then I wonder if that wouldn't help her because remember he said it sometimes she says, I don't want to do that, it makes oh my edema hurt or something.
- 21:04SPEAKER_00: Oh, okay.
- 21:06SPEAKER_00: Yeah.
- 21:10SPEAKER_00: Okay.
- 21:11SPEAKER_00: And and that seems to be good for her.
- 21:14SPEAKER_00: All right, fair enough.
- 21:17SPEAKER_00: So we we sure agree with Dr.
- 21:21SPEAKER_00: Song that this hyperthermia or heating is is a really good idea.
- 21:26SPEAKER_00: So all of this shows, Joe, you you know, that she like every most everybody is taking standard uh standard of care within the guidelines.
- 21:41SPEAKER_00: But it shows how many other things we can do.
- 21:46SPEAKER_00: Right.
- 21:49SPEAKER_00: And and and as Dr.
- 21:52SPEAKER_00: Eczeme always said, if you use standard of care, just use standard of care, you're gonna get a standard outcome.
- 22:01SPEAKER_00: Exactly.
- 22:02SPEAKER_00: So but standard outcome for ninety-nine percent or whatever of the cancers, not great.
- 22:11SPEAKER_00: It's it's good, but not good enough.
- 22:13SPEAKER_00: Not great, that's for sure.
- 22:19SPEAKER_00: We have to be creative and scientifically creative, so so uh in her case, even though she has extensive cancer, we're going for a complete response.
- 22:35SPEAKER_01: Absolutely.
- 22:36SPEAKER_01: I I think I'm I'm gaining an understanding a little bit about it.
- 22:41SPEAKER_01: Seems that when somebody has a treatment, whatever the treatment is, and they get a recovery, and if they get a recurrence, which more than likely they will, at one point, it seems that the second round is usually.
- 23:00SPEAKER_01: Usually worse than the first round.
- 23:02SPEAKER_01: If the change occurs that's what I'm saying.
- 23:06SPEAKER_00: And now I've almost certainly has changed.
- 23:10SPEAKER_00: Right.
- 23:11SPEAKER_00: It overcame the treatment that uh would would was able to eradicate the majority of it.
- 23:18SPEAKER_00: Right.
- 23:18SPEAKER_00: These guys are the really bad guys.
- 23:21SPEAKER_01: Yeah.
- 23:22SPEAKER_00: They either were or acquired resistance to the first line of treatment.
- 23:31SPEAKER_00: Right.
- 23:31SPEAKER_00: And by doing so, they probably became more malignant.
- 23:37SPEAKER_00: There's a there's a number of studies over the years in that drug-resistant cancers are more malignant.
- 23:46SPEAKER_00: It makes sense.
- 23:48SPEAKER_00: So recurrence is very bad because it it probably, maybe not in every case, but I bet no majority of cases we don't know for sure, but it looks like the cancer is different than what it was in the beginning.
- 24:10SPEAKER_00: It has acquired resistance to the treatment and in so doing it i it's it we see how malleable it is.
- 24:19SPEAKER_00: It's become more malignant.
- 24:21SPEAKER_00: It's very easy for a cancer to become more malignant.
- 24:24SPEAKER_00: It's already it's kind of it's it can't regulate its uh its genome very well like uh normal cells and tissues.
- 24:35SPEAKER_00: It has sometimes more chromosomes and and breaking of chromosomes.
- 24:40SPEAKER_00: So it it has a hard time in be in becoming a cancer or maybe that's really part of becoming a cancer, but the genome gets uh dysregulated.
- 24:52SPEAKER_00: It it's not you know the the true 46 chromosomes we have in all our cells, and every one of them is good.
- 25:01SPEAKER_00: The cancer already has changes in its genome.
- 25:07SPEAKER_00: Probably that's how it's uh very important for it to become a cancer.
- 25:11SPEAKER_00: And but it means it can make more changes.
- 25:16SPEAKER_00: It's not stable anymore.
- 25:18SPEAKER_00: And and so we have this is what we have to stay ahead of it.
- 25:23SPEAKER_00: We have to s stay ahead of it.
- 25:25SPEAKER_00: Cancer being so easily changeable and being easily changeable means it can become more malignant.
- 25:33SPEAKER_00: And so we have to stay ahead of that.
- 25:37SPEAKER_00: Now uh I'm very intrigued by Dr.
- 25:40SPEAKER_00: Gatenby.
- 25:44SPEAKER_00: He uh goes on and off with his treatment, most of it is antigen deprivation therapy for prostate cancer.
- 25:53SPEAKER_00: He just doesn't give a chance for the cancers to be under low uh hormone conditions for a long period of time.
- 26:02SPEAKER_00: That is the selective condition for the bad guys that don't need the hormone and they grow well.
- 26:10SPEAKER_00: So this is what he wants he his his his objective is and he said and quite a statement you do this adaptive therapy and prostate cancer is no longer a lethal disease, and I think variations of that for every cancer can be done.
- 26:31SPEAKER_00: So they no cancer becomes a lethal disease.
- 26:35SPEAKER_00: That's quite a statement.
- 26:38SPEAKER_00: But I think it's I think it's possible.
- 26:41SPEAKER_01: It's certainly worthy of an effort when you look at the alternative in some cases, and it's things like very aggressive, toxic, and and harmful procedures when trying to cycle a drug off and on or rotating drugs, to me, it seems like you can monitor the progress with scans and blood work and marker tests.
- 27:11SPEAKER_01: Yeah, you just have to be diligent, and and it it takes an effort and it takes some resources, but it just seems like rather than you know dropping a nuclear bomb inside your body and hoping that something survives, it it just seems like a better way.
- 27:30SPEAKER_00: Well, or or yeah, for sure.
- 27:33SPEAKER_00: And and like we decided with you, we said, well, let's try the chemo first.
- 27:39SPEAKER_00: We could we can always do the radiation if we have to, but let's just see.
- 27:44SPEAKER_00: Let's just see.
- 27:45SPEAKER_00: Maybe maybe we'll get a really good result, and we got an amazing result.
- 27:49SPEAKER_01: Yes, we did.
- 27:51SPEAKER_00: So and the and the doctors at at UCI wouldn't let let you get that result.
- 27:59SPEAKER_01: Uh no, they wouldn't let me touch the the immunotherapy either.
- 28:04SPEAKER_00: Chemo, and then they wanted to irradiate you, and that wouldn't have that wouldn't have been good.
- 28:12SPEAKER_01: No, I'll take the I'll take the immunotherapy anytime.
- 28:17SPEAKER_01: I go home, I take a little nap, I wake up, I feel fine, and I can swallow my food, and I can talk, and I can I can chew, I have teeth and and a jawbone, and all those good things.
- 28:34SPEAKER_00: I feel so, you know, you tell me about your your your chat group with uh head and neck cancer, and they're all disfigured by the surgery and the radiation, all recurring.
- 28:49SPEAKER_01: I I saw a photo of a guy where they removed his nose and they're grafting on some blob that I guess is gonna be a nose at one point, and the guy just looked so horribly miserable.
- 29:04SPEAKER_00: Oh, the poor guy, you know, and it was probably a local cancer, he probably had called nasal pharyngeal cancer, yeah.
- 29:14SPEAKER_00: I don't know.
- 29:15SPEAKER_00: And you know, I don't know.
- 29:20SPEAKER_00: Um I just think your case is a good example.
- 29:25SPEAKER_00: Can you make a an can you make a general conclusion out of a case of one?
- 29:31SPEAKER_01: Of course not, but it's but it's certainly worthy of exploring if you get a dramatic result in one case.
- 29:39SPEAKER_01: That's a fairly standard case.
- 29:41SPEAKER_01: Like my age ground graph, my age group, the type of cancer, the the associated factors, all those things are a fairly standard group.
- 29:55SPEAKER_01: I I I fit the age and the the thing that there's a lot of people in that in that bracket.
- 30:01SPEAKER_01: So if it worked for me, it would just almost seem like a a note-brainer to say, well, maybe we should try it.
- 30:09SPEAKER_01: We have all these other people that have a similar problem.
- 30:13SPEAKER_00: Well, I mean, we're not talking about something radical, go do something, you know, radical.
- 30:20SPEAKER_00: We we say all the first-line therapy, but why we can't just kind of do it in steps?
- 30:29SPEAKER_00: Chemo radiation.
- 30:30SPEAKER_00: Can we try chemo first with good good first line chemo?
- 30:35SPEAKER_01: Well, and even the notion of the diet that no nobody diet to me is a given.
- 30:42SPEAKER_00: Right.
- 30:43SPEAKER_00: About that diet since Tsugimura did it with his rats in 1959.
- 30:47SPEAKER_00: We know that every cancer patient should be on a low methionine diet, and yeah, and uh and then nobody knows.
- 30:55SPEAKER_00: And so, and that's almost 70 years ago.
- 30:59SPEAKER_01: And well, you know what?
- 31:03SPEAKER_01: Some some new people know because of our conversations, and I know that for a fact because I've had people bring it to my attention, and so you know what we're doing is is helpful, it's keeping the conversation.
- 31:16SPEAKER_01: Google is making a transcript of this podcast, and every word of that transcript is cataloged, and so little by little, the it's intertwining into the web of knowledge.
- 31:32SPEAKER_01: I wanted to briefly get into we had some new patients that joined the group, and I want to talk about the group real briefly, but we we mention it every time we talk.
- 31:43SPEAKER_01: Every Sunday at 4 p.m.
- 31:46SPEAKER_01: Pacific time, uh, we have a Zoom call.
- 31:49SPEAKER_01: And on that Zoom call, Dr.
- 31:51SPEAKER_01: Hoffman joins us, Shiro, Gene Slattery, and and oftentimes Dr.
- 31:56SPEAKER_01: Emil Exame, Dr.
- 31:59SPEAKER_01: Fox, a few other doctors.
- 32:01SPEAKER_01: There's a doctor from well, she's from Romania now, right?
- 32:05SPEAKER_01: She's from Ukraine.
- 32:11SPEAKER_01: Catherine.
- 32:12SPEAKER_01: Yeah, yeah.
- 32:13SPEAKER_01: And then and then you've got your the other guy that kind of I forget his name.
- 32:17SPEAKER_01: I'm yeah.
- 32:19SPEAKER_01: So we have a bunch of doctors that are on, but we have Dr.
- 32:23SPEAKER_01: Bonaris.
- 32:25SPEAKER_01: We have most importantly, many of these doctors are patients as well, and we have patients such as myself and Shahiro and all the people, a lot of a lot of cancer or of prostate cancer males and a number of breast cancer females, but it's all over the place.
- 32:46SPEAKER_01: My my cancer, I haven't seen a lot of people with it, but but there's been a couple, some glioblastoma, pancreatic cancer.
- 32:54SPEAKER_01: We've had a pretty much all over the board.
- 32:57SPEAKER_01: We have a new patient that came in.
- 33:01SPEAKER_01: This why don't you give us a quick little summary of what what they're doing?
- 33:04SPEAKER_00: Yeah, a new patient has glioblastoma, and uh he's I don't know.
- 33:10SPEAKER_01: Which is a brain cancer for those people who don't know.
- 33:13SPEAKER_00: Yeah, very it's called incurable, but we've cured one girl.
- 33:20SPEAKER_00: So, what I like about this patient is his wife is so diligent.
- 33:29SPEAKER_00: Yes, she gets it, she understands, she she understands, hey, yeah, wait a minute, this uh low methionine diet makes sense.
- 33:37SPEAKER_00: Yeah, it's uh really foolish not to be on it, and so they're on it, and they're they're gonna start methioninase, and they're gonna they're gonna be taking the standard drug, which is tamazolamide.
- 33:52SPEAKER_00: So I think they have a good chance to be on it, to get a good response.
- 33:59SPEAKER_00: You know, we had this mother on for a long time, this kind of writer, actress lady, very beautiful lady, telling us about her son who never came out and then some uh I don't know, some doctor came in and kind of got him off track.
- 34:22unknown: I don't know.
- 34:23SPEAKER_01: Yeah, all of a sudden they stopped coming around.
- 34:24SPEAKER_01: I have it's been a little while.
- 34:26SPEAKER_00: Oh, you're gonna compromise the immunotherapy if you're on methionine restriction.
- 34:33unknown: Dr.
- 34:33SPEAKER_00: Ishiguro just gave me a new paper today.
- 34:36SPEAKER_00: I'm trying to digest it a little bit and showing methionine restriction uh promotes immunotherapy.
- 34:45SPEAKER_00: Paper after paper, one or two dissenting papers that are probably all wrong, but the the paper after paper shows methionine restriction enhances immunotherapy, but apparently, you know, somebody just got her off off track and she doesn't come on anymore.
- 35:09SPEAKER_00: Yeah.
- 35:10SPEAKER_00: It's tough.
- 35:11SPEAKER_00: It's really tough for the cancer patient because they're kind of out there all by themselves.
- 35:17SPEAKER_00: Exactly.
- 35:18SPEAKER_00: The psychologist is telling you this is what you gotta do.
- 35:23SPEAKER_00: And you know, and and and in a very authoritative way, all most of them, this is what you gotta do.
- 35:30SPEAKER_00: This is the only thing.
- 35:31SPEAKER_00: Yeah.
- 35:32SPEAKER_01: And and you know, Robert, if it wasn't for you and the group, I probably would have gone down and got that radiation because I just didn't know any better, and they were insistent.
- 35:43SPEAKER_00: There was no major university, yeah, a world-class university hospital, University of California Irving Hospital.
- 35:52SPEAKER_00: Yeah, radiation, Joe.
- 35:55SPEAKER_00: That's the guideline.
- 35:56SPEAKER_00: Who are you?
- 35:57SPEAKER_00: Who are you to not get it on the guideline?
- 36:00SPEAKER_00: Exactly.
- 36:01SPEAKER_00: So uh you know, it and it was very interesting on our last Zoom on on Sunday, Ann, who was used to be a regular, and oh yeah, and then disappeared.
- 36:16SPEAKER_00: Yeah, she got a recurrence, right?
- 36:19SPEAKER_00: She might not have gotten if she would have had hung in there, but anyway, right, she was all set to get radiation.
- 36:26SPEAKER_01: Right.
- 36:27SPEAKER_00: Chemo.
- 36:28SPEAKER_00: So she came over, had picked up her methionase, which she's newly on again, and I said, Ann, why don't you ask these docs what's the side effects gonna be with you getting all this radiation?
- 36:45SPEAKER_00: Right.
- 36:45SPEAKER_00: All of a sudden they said, Oh, oh, you don't need it, it's uh just for the pain.
- 36:50SPEAKER_00: They they completely changed and they called her up.
- 36:52SPEAKER_00: She must have pressed some button there that yeah, that that that they got all, you know.
- 36:59SPEAKER_00: Holy maybe we shouldn't be telling the patient all uh telling the patient all this stuff.
- 37:07SPEAKER_00: Right.
- 37:08SPEAKER_00: So that now the next thing is I worry about that the chemo that that she's being proposed that's being proposed for her, I don't think is strong enough.
- 37:22SPEAKER_00: Oh um, I've asked her a number of times to come with me to Dr.
- 37:27SPEAKER_00: Songs.
- 37:28SPEAKER_00: Uh but and she lives down here in Southern California.
- 37:32SPEAKER_00: Yeah, she lives in San and she's I think she's a neighbor of Dr.
- 37:35SPEAKER_00: Exchange.
- 37:36SPEAKER_01: Oh wow.
- 37:38SPEAKER_00: Or they go to the same church or whatever.
- 37:40SPEAKER_00: Um I think you know she she she's one of the she's like most patients, she doesn't want to go against her oncologist.
- 37:52SPEAKER_00: You know, I mean, I think any cancer patient, every cancer patient should get a second opinion, third opinion.
- 37:58SPEAKER_00: Oh, at least very least, yeah.
- 38:02SPEAKER_00: I don't think she's gonna do it.
- 38:04SPEAKER_00: I hope I'm hoping, but I I kind of pushed her as much as I think I should, or more than I hear you.
- 38:11SPEAKER_00: She's gonna get this one kind of estrogen degrader, and that's good, and and one of these syslibs, the the so-called targeted therapy, and and that's good.
- 38:23SPEAKER_00: She needs to have a cytotoxic in there, like Dr.
- 38:26SPEAKER_00: Song proposed for Chihiro.
- 38:29SPEAKER_00: What she's getting, I don't think is enough.
- 38:31SPEAKER_00: And it's great that she's back on methionine restriction.
- 38:36SPEAKER_00: She has breast cancer, metastatic to the bone, and wherever else.
- 38:41SPEAKER_00: And uh it must be at this stage extremely aggressive.
- 38:48SPEAKER_01: Well, and and when once it starts spreading like that, a radiation treatment's not going to solve it because it's a local treatment.
- 38:58SPEAKER_01: It doesn't, it's not a systemic thing.
- 39:01SPEAKER_01: Well, chemo is.
- 39:04SPEAKER_00: It can be systemic.
- 39:06SPEAKER_00: That that that's what Dr.
- 39:08SPEAKER_00: Sato does.
- 39:09SPEAKER_00: He does this immunordiation.
- 39:10SPEAKER_00: Oh, okay.
- 39:11SPEAKER_00: I'm I'm not aware of what it what it is.
- 39:15SPEAKER_00: If you especially if you take immunotherapy for that, but I talked with Dr.
- 39:20SPEAKER_00: Ishiguro and he's worried there might be some really strong side effects to that.
- 39:26SPEAKER_00: So we're putting putting that on hold for a while.
- 39:29SPEAKER_00: Okay.
- 39:30SPEAKER_00: See how we do without all that stuff.
- 39:34SPEAKER_00: But gener, you know, generally it's local.
- 39:37SPEAKER_00: Gene Slattery had some local radiation.
- 39:41SPEAKER_00: It was the most worst thing that ever happened to him.
- 39:44SPEAKER_01: Sounded like it, yeah.
- 39:45SPEAKER_00: Uh it was it was so awful, so terrible.
- 39:50SPEAKER_00: So I don't know.
- 39:52SPEAKER_00: So we'll see.
- 39:54SPEAKER_00: Maybe Ann will get started on this, and we'll just see how she does with her blood markers and her and her and her scans.
- 40:04SPEAKER_00: And you know, maybe she'll do good, but if she doesn't do good, that that'll be enough to stimulate her to go see Dr.
- 40:11SPEAKER_00: Song, I'm sure.
- 40:13SPEAKER_00: You know, I would go right now, but okay.
- 40:18SPEAKER_00: She knows.
- 40:19SPEAKER_00: I said, I'll go with you, and so I'm kind of done with that.
- 40:23SPEAKER_01: And yeah, yeah.
- 40:24SPEAKER_01: She tells me you can't, you know, you can only do so much in trying to help people.
- 40:28SPEAKER_01: You know, you and I've talked about this a number of times, like all the people that come out reach out to me, and then when I start talking to about you know the hard work it's gonna be, they they nine out of ten times they glaze over, and now I just say, Well, before I talk to you, you know, how bad do you want to live?
- 40:48SPEAKER_01: And if that answer isn't ferocious, I just say, Well, you're probably you probably know better than I do, you know.
- 40:56SPEAKER_01: But if you decide you really want to live, then let's talk.
- 41:00SPEAKER_01: Because you gotta have that, otherwise it's not gonna be enough.
- 41:04SPEAKER_01: Most important medicine of all that the spirit to live.
- 41:08SPEAKER_00: Yes, I couldn't agree more.
- 41:10SPEAKER_00: You know, when they tell you to go to the hospice and you got one month, and that's what it is, it's one month because that's exactly and you're so dispirited, you lose your your your passion for life.
- 41:24SPEAKER_00: So the the the oncologist is almost always right when they tell you you're gonna die in a certain amount of time, it happens because the oncologist has taken away your life's your life force.
- 41:35SPEAKER_01: You know, just uh recently a dear friend of my wife's was diagnosed with lung cancer, and you know, the guy smoked for 50 years and and was never gonna give that up.
- 41:49SPEAKER_01: We went to visit him, and he was he went from a healthy guy or or you know, a strong guy who was out doing everything, you know, he's in his 70s, I think, early 70s, but a robust guy used to be a hang glider pilot, construction guy, you know, just a guy that was out there.
- 42:17SPEAKER_01: And all of a sudden we we we come to see him, and this was less than a couple weeks after he was diagnosed, and the doctor told him, you know, you got a short period of time to live.
- 42:28SPEAKER_01: And he was tucked into a hospice bed, and he had already lost I don't know, a quarter of his body weight.
- 42:37SPEAKER_01: He was, you could just tell he was he was literally just sitting there waiting to die.
- 42:43SPEAKER_01: In fact, he got a little frustrated when he didn't die as early as he thought.
- 42:47SPEAKER_01: He's like, Well, I don't know why I'm still here.
- 42:50SPEAKER_01: Like that was his, and it I I went and visited one time.
- 42:54SPEAKER_01: I'm like, I can't do this again.
- 42:55SPEAKER_01: I can't, I can't, there's nothing I could say that would help this guy.
- 43:01SPEAKER_01: And I just it it blew my mind to see somebody that was willing to give up, you know, and not even try, not even like there was not until the doctor told him to give up.
- 43:15SPEAKER_00: Yeah, and and and if that happened to me, maybe I'd give up too.
- 43:20SPEAKER_00: I mean, this is terrible, yeah.
- 43:23SPEAKER_00: And it they say, well, there's nothing we can do, uh, and uh and and you know, as Tonno said to the Lone Ranger, what do you mean we, white man?
- 43:35SPEAKER_01: Exactly, exactly.
- 43:37SPEAKER_01: There's there's no we involved, yeah.
- 43:40SPEAKER_00: Uh you know, there's a point where you can't come back, there's a point where you know you just there's a point.
- 43:50SPEAKER_00: I I get it, but that's a long way away from diagnosis and and I mean even when you're really, really advanced, maybe, maybe if you go on with very severe methionine restriction, you could stop the progression a little bit, right?
- 44:09SPEAKER_00: And and and get a little foot in the door, yeah.
- 44:13SPEAKER_00: And for the next step.
- 44:17SPEAKER_00: I mean, I wouldn't recommend somebody who's really, really going downhill that to to just blast them with a lot of chemo, but how about just really strict with high name restriction, just to try to stop that stop that freight train and and get a little break and and let us do the next thing?
- 44:45SPEAKER_00: Um, I shouldn't agree more.
- 44:48SPEAKER_00: Your friend or your wife's friend, I think he had enough left in him that if the doctor could have, yeah, uh, we're gonna try something a little bit out of the box.
- 44:58SPEAKER_00: Uh we can't promise you anything except hope.
- 45:02SPEAKER_00: Yeah, uh, but we're not gonna take your hope away.
- 45:05SPEAKER_00: Exactly.
- 45:06SPEAKER_00: Oh my god.
- 45:07SPEAKER_01: No, he had no hope at all.
- 45:09SPEAKER_01: He ended up the oncologist took away his hope.
- 45:13SPEAKER_01: Yeah, 100%.
- 45:17SPEAKER_01: 100%.
- 45:17SPEAKER_01: It was one of the saddest things I've experienced in a while, because I mean I knew the guy, I used to go fishing with him, and you know, we we he loved my daughters and and and you know was really good to our family.
- 45:31SPEAKER_01: And you know, I and I thought he was a good guy, but when I saw that, I just it it kind of but and the oncologist is a good person too.
- 45:42SPEAKER_00: He he keep doing what is in the guideline, you see doing what they know, yeah.
- 45:49SPEAKER_00: And you say hospice, that's what that's the guideline.
- 45:53SPEAKER_00: I get it, I get it.
- 45:54SPEAKER_00: Guideline, that's what the oncologist is doing, that's what they're trained to do.
- 45:59SPEAKER_00: Uh, but that's a mistraining.
- 46:02SPEAKER_00: I couldn't agree more.
- 46:03SPEAKER_01: Well, Robert, as always, I love these conversations.
- 46:08SPEAKER_01: I I look forward to doing this a little more regularly.
- 46:12SPEAKER_01: We we got me talking.
- 46:15SPEAKER_01: I'm around.
- 46:16SPEAKER_01: Yeah, when we don't talk a lot, we end up doing long episodes, and I'd rather do a bunch of shorter episodes because they're like I'm all for yeah, yeah, but I didn't want to miss out.
- 46:27SPEAKER_01: We had a lot to catch up on.
- 46:28SPEAKER_01: I'd like to maybe next time we talk, get back into your work and and some of the work you're you're working on and and all of that.
- 46:35SPEAKER_01: But um always a pleasure, and and I'll I'll say it once, I've said it a thousand times, Dr.
- 46:41SPEAKER_01: Hoffman.
- 46:42SPEAKER_01: It if it wasn't for me meeting you and you answering the call when I just randomly reached out for methioninase, I don't know if I'd be sitting here today, right now, the way I am.
- 46:53SPEAKER_01: And but here I am, and here and that and you know you know what I say to all of listeners out there, oh listen to Joe.
- 47:06SPEAKER_01: Well, I can do my best to listen to tunes in.
- 47:12SPEAKER_01: I do my best to echo what I've learned from you and all the others.
- 47:16SPEAKER_01: So well, the what you've learned most is from your yourself.
- 47:19SPEAKER_00: You saw us exactly you had a grapefruit on your neck and it disappeared in the few weeks.
- 47:27SPEAKER_01: No, I don't.
- 47:27SPEAKER_01: Yep, exactly.
- 47:29SPEAKER_01: All right, well, Robert, thank you so much.
- 47:31SPEAKER_01: We'll uh we'll get back to it next week.
- 47:35SPEAKER_01: And this has been another anytime.
- 47:38SPEAKER_01: I'm here.
- 47:39SPEAKER_01: Beautiful.
- 47:39SPEAKER_01: This has been another episode of the Healthy Living Podcast.
- 47:42SPEAKER_01: I'm your host, Joe Grumbine, and I want to thank all the listeners for making the show possible, and we will see you next time.